Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018 Apr;16(4):359–369.
   PubMed Web of Science ®Google Scholar
• Cao Y. Adipocyte and lipid metabolism in cancer drug resistance. J Clin Invest. 2019 Jul 2;129(8):3006–3017. doi: 10.1172/JCI127201
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019 Oct 19;394(10207):1467–1480. doi: 10.1016/S0140-6736(19)32319-0
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222. doi: 10.1080/15548627.2015.1100356
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017 Sep;17(9):528–542. doi: 10.1038/nrc.2017.53
   PubMed Web of Science ®Google Scholar
• Dong L, He J, Luo L, et al. Targeting the interplay of autophagy and ROS for cancer therapy: an updated overview on phytochemicals. Pharmaceuticals (Basel). 2023 Jan 8;16(1):92. doi: 10.3390/ph16010092
   PubMedGoogle Scholar
• Dou Q, Chen HN, Wang K, et al. Ivermectin induces cytostatic autophagy by blocking the PAK1/Akt Axis in breast cancer. Cancer Res. 2016 Aug 1;76(15):4457–4469. doi: 10.1158/0008-5472.CAN-15-2887
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhang L, Chen H, et al. Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma. Autophagy. 2020 Jan;16(1):106–122.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu R, Li J, et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-Mtor- and hypoxia-induced factor 1alpha-mediated signaling. Autophagy. 2011 Sep;7(9):966–978.
   PubMed Web of Science ®Google Scholar
• Xia Y, Xu F, Xiong M, et al. Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux. Pharmacol Res. 2021 Jan;163:105295.
   PubMed Web of Science ®Google Scholar
• Yan C, Luo L, Guo CY, et al. Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells. Cancer Lett. 2017 Mar 1;388:34–42. doi: 10.1016/j.canlet.2016.11.018
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhou L, Xie N, et al. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther. 2020 Jul 2;5(1):113. doi: 10.1038/s41392-020-00213-8
   PubMed Web of Science ®Google Scholar
• Anding AL, Baehrecke EH. Cleaning house: selective autophagy of organelles. Dev Cell. 2017 Apr 10;41(1):10–22. doi: 10.1016/j.devcel.2017.02.016
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen HN, Wang K, et al. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol. 2019 Jan;70(1):66–77.
   PubMed Web of Science ®Google Scholar
• Dany M, Gencer S, Nganga R, et al. Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML. Blood. 2016 Oct 13;128(15):1944–1958. doi: 10.1182/blood-2016-04-708750
   PubMed Web of Science ®Google Scholar
• Sentelle RD, Senkal CE, Jiang W, et al. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat Chem Biol. 2012 Oct;8(10):831–838.
   PubMed Web of Science ®Google Scholar
• Yun WJ, Yao ZH, Fan CL, et al. Systematic screening and characterization of Qi-Li-Qiang-Xin capsule-related xenobiotics in rats by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jul 15;1090:56–64. doi: 10.1016/j.jchromb.2018.05.014
   PubMed Web of Science ®Google Scholar
• Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol. 2013 Sep 17;62(12):1065–1072. doi: 10.1016/j.jacc.2013.05.035
   PubMed Web of Science ®Google Scholar
• Cheng CF, Lu IH, Tseng HW, et al. Antitumor effect of periplocin in TRAIL-Resistant human hepatocellular carcinoma cells through downregulation of IAPs. Evid Based Complement Alternat Med. 2013;2013:958025. doi: 10.1155/2013/958025
   PubMed Web of Science ®Google Scholar
• Du YY, Liu X, Shan BE. Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/beta-catenin signaling pathway. Ai Zheng. 2009 May;28(5):456–460.
   PubMedGoogle Scholar
• Lohberger B, Bernhart E, Stuendl N, et al. Periplocin mediates TRAIL-induced apoptosis and cell cycle arrest in human myxofibrosarcoma cells via the ERK/p38/JNK pathway. Phytomedicine. 2020 Jun 5;76:153262. doi: 10.1016/j.phymed.2020.153262
   PubMed Web of Science ®Google Scholar
• Xie G, Sun L, Li Y, et al. Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-Mtor signaling. Cancer Med. 2021 Jan;10(1):325–336.
   PubMed Web of Science ®Google Scholar
• Zhao L, Shan B, Du Y, et al. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling. Oncol Rep. 2010 Aug;24(2):375–383.
   PubMed Web of Science ®Google Scholar
• Zhao LM, Li L, Huang Y, et al. Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway. Mol Carcinog. 2019 Jun;58(6):1033–1045.
   PubMed Web of Science ®Google Scholar
• Wang F, Gomez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic. 2018 Dec;19(12):918–931. doi: 10.1111/tra.12613
   PubMed Web of Science ®Google Scholar
• Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol. 2009 Sep;10(9):623–635. doi: 10.1038/nrm2745
   PubMed Web of Science ®Google Scholar
• Fehrenbacher N, Bastholm L, Kirkegaard-Sorensen T, et al. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res. 2008 Aug 15;68(16):6623–6633. doi: 10.1158/0008-5472.CAN-08-0463
   PubMed Web of Science ®Google Scholar
• Cao Q, Yang Y, Zhong XZ, et al. The lysosomal Ca(2+) release channel TRPML1 regulates lysosome size by activating calmodulin. J Biol Chem. 2017 May 19;292(20):8424–8435. doi: 10.1074/jbc.M116.772160
   PubMed Web of Science ®Google Scholar
• Cao Q, Zhong XZ, Zou Y, et al. Calcium release through P2X4 activates calmodulin to promote endolysosomal membrane fusion. J Cell Bio. 2015 Jun 22;209(6):879–894. doi: 10.1083/jcb.201409071
   PubMed Web of Science ®Google Scholar
• Saffi GT, Botelho RJ. Lysosome fission: planning for an exit. Trends Cell Biol. 2019 Aug;29(8):635–646. doi: 10.1016/j.tcb.2019.05.003
   PubMed Web of Science ®Google Scholar
• Aits S, Kricker J, Liu B, et al. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy. 2015;11(8):1408–1424. doi: 10.1080/15548627.2015.1063871
   PubMed Web of Science ®Google Scholar
• Papadopoulos C, Meyer H. Detection and clearance of damaged lysosomes by the endo-lysosomal damage response and lysophagy. Curr Biol. 2017 Dec 18;27(24):R1330–R1341. doi: 10.1016/j.cub.2017.11.012
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Bravo-San Pedro JM, Levine B, et al. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 2017 Jul;16(7):487–511.
   PubMed Web of Science ®Google Scholar
• Wang Y, Qiu Q, Shen JJ, et al. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways. Int J Biochem Cell Biol. 2012 Nov;44(11):1813–1824.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Murphy LO. Autophagy assays for biological discovery and therapeutic development. Trends Biochem Sci. 2020 Dec;45(12):1080–1093. doi: 10.1016/j.tibs.2020.07.006
   PubMed Web of Science ®Google Scholar
• Green DR, Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell. 2014 Mar 27;157(1):65–75. doi: 10.1016/j.cell.2014.02.049
   PubMed Web of Science ®Google Scholar
• Jia J, Abudu YP, Claude-Taupin A, et al. Galectins control mTOR in response to endomembrane damage. Mol Cell. 2018 Apr 5;70(1):120–135 e8. doi: 10.1016/j.molcel.2018.03.009
   PubMed Web of Science ®Google Scholar
• Jia J, Bissa B, Brecht L, et al. AMPK, a regulator of metabolism and autophagy, is activated by lysosomal damage via a novel galectin-directed ubiquitin signal transduction system. Mol Cell. 2020 Mar 5;77(5):951–969 e9. doi: 10.1016/j.molcel.2019.12.028
   PubMed Web of Science ®Google Scholar
• Chauhan S, Kumar S, Jain A, et al. Trims and galectins globally cooperate and TRIM16 and galectin-3 co-direct autophagy in endomembrane damage homeostasis. Dev Cell. 2016 Oct 10;39(1):13–27. doi: 10.1016/j.devcel.2016.08.003
   PubMed Web of Science ®Google Scholar
• Jia J, Claude-Taupin A, Gu Y, et al. Galectin-3 coordinates a cellular system for lysosomal repair and removal. Dev Cell. 2020 Jan 6;52(1):69–87 e8. doi: 10.1016/j.devcel.2019.10.025
   PubMed Web of Science ®Google Scholar
• Radulovic M, Schink KO, Wenzel EM, et al. ESCRT-mediated lysosome repair precedes lysophagy and promotes cell survival. Embo J. 2018 Nov 2;37(21). doi: 10.15252/embj.201899753
   PubMed Web of Science ®Google Scholar
• Skowyra ML, Schlesinger PH, Naismith TV, et al. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science. 2018 Apr 6;360(6384). doi: 10.1126/science.aar5078
   PubMed Web of Science ®Google Scholar
• Maejima I, Takahashi A, Omori H, et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. Embo J. 2013 Aug 28;32(17):2336–2347. doi: 10.1038/emboj.2013.171
   PubMed Web of Science ®Google Scholar
• Papadopoulos C, Kirchner P, Bug M, et al. VCP/P97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. Embo J. 2017 Jan 17;36(2):135–150. doi: 10.15252/embj.201695148
   PubMed Web of Science ®Google Scholar
• Yao RQ, Ren C, Xia ZF, et al. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. Autophagy. 2021 Feb;17(2):385–401.
   PubMed Web of Science ®Google Scholar
• Elia AE, Boardman AP, Wang DC, et al. Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response. Mol Cell. 2015 Sep 3;59(5):867–881. doi: 10.1016/j.molcel.2015.05.006
   PubMed Web of Science ®Google Scholar
• Cragg GM, Grothaus PG, Newman DJ. Impact of natural products on developing new anti-cancer agents. Chem Rev. 2009 Jul;109(7):3012–3043. doi: 10.1021/cr900019j
   PubMed Web of Science ®Google Scholar
• Cao Y. Obesity protects cancer from drugs targeting blood vessels. Cell Metab. 2018 Jun 5;27(6):1163–1165. doi: 10.1016/j.cmet.2018.05.014
   PubMed Web of Science ®Google Scholar
• Chen X, Wang Y, Ma N, et al. Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification. Signal Transduct Target Ther. 2020 May 21;5(1):72. doi: 10.1038/s41392-020-0186-y
   PubMed Web of Science ®Google Scholar
• Efferth T, Saeed MEM, Kadioglu O, et al. Collateral sensitivity of natural products in drug-resistant cancer cells. Biotechnol Adv. 2020 Jan - Feb;38:107342.
   PubMed Web of Science ®Google Scholar
• Sun Y, Huang YH, Huang FY, et al. 3’-epi-12beta-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells. Theranostics. 2018;8(7):2044–2060. doi: 10.7150/thno.23304
   PubMed Web of Science ®Google Scholar
• Boya P, Gonzalez-Polo RA, Poncet D, et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene. 2003 Jun 19;22(25):3927–3936. doi: 10.1038/sj.onc.1206622
   PubMed Web of Science ®Google Scholar
• Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer. 2005 Nov;5(11):886–897. doi: 10.1038/nrc1738
   PubMed Web of Science ®Google Scholar
• Ballabio A, Bonifacino JS. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 2020 Feb;21(2):101–118. doi: 10.1038/s41580-019-0185-4
   PubMed Web of Science ®Google Scholar
• Song Y, Luo L, Wang K. Off-target identification by chemical proteomics for the understanding of drug side effects. Expert Rev Proteomics. 2020 Oct;17(10):695–697. doi: 10.1080/14789450.2020.1873134
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Yasuda S, Fujita T, et al. Ubiquitination of exposed glycoproteins by SCF(FBXO27) directs damaged lysosomes for autophagy. Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8574–8579. doi: 10.1073/pnas.1702615114
   PubMed Web of Science ®Google Scholar
• Kim SJ, Chun KH. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner. BMB Rep. 2020 Apr;53(4):173–180. doi: 10.5483/BMBRep.2020.53.4.020
   PubMed Web of Science ®Google Scholar
• Kim SJ, Choi IJ, Cheong TC, et al. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology. 2010 Mar;138(3):1035-45 e1–2.
   Web of Science ®Google Scholar
• Song S, Byrd JC, Mazurek N, et al. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation. Gastroenterology. 2005 Nov;129(5):1581–1591.
   PubMed Web of Science ®Google Scholar
• Castronovo V, Van Den Brule FA, Jackers P, et al. Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol. 1996 May;179(1):43–48.
   PubMed Web of Science ®Google Scholar
• Pacis RA, Pilat MJ, Pienta KJ, et al. Decreased galectin-3 expression in prostate cancer. Prostate. 2000 Jul 1;44(2):118–123. doi: 10.1002/1097-0045(20000701)44:2<118:AID-PROS4>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• He X, Yin X, Wu J, et al. Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo. Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22910–22919. doi: 10.1073/pnas.2009092117
   PubMed Web of Science ®Google Scholar
• Hosaka K, Yang Y, Seki T, et al. Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors. Nat Commun. 2020 Jul 24;11(1):3704. doi: 10.1038/s41467-020-17525-6
   PubMed Web of Science ®Google Scholar
• Wang K, Luo L, Fu S, et al. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. Nat Commun. 2023 Feb 23;14(1):1011. doi: 10.1038/s41467-023-36708-5
   PubMed Web of Science ®Google Scholar
• Sun X, He X, Zhang Y, et al. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut. 2022 Jan;71(1):129–147.
   PubMed Web of Science ®Google Scholar
• Andersson P, Yang Y, Hosaka K, et al. Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis. JCI Insight. 2018 Oct 18;3(20). doi: 10.1172/jci.insight.122375
   Web of Science ®Google Scholar